Gujarat Inject (Kerala) Limited (BSE: 524238) has officially announced a revision to the Record Date for its upcoming sub-division/split of equity shares. As per the official intimation submitted to BSE Limited by the Company Secretary & Compliance Officer, the revised Record Date is now set for Wednesday, July 8, 2026, superseding the previously scheduled date of July 2, 2026.
This highly anticipated corporate action is strategically timed alongside the company's explosive financial growth and a major operational transition into India's booming renewable energy sector.
Strategic Focus: The 10:1 Stock Split Mechanics
A stock split divides existing corporate shares into multiple units without altering the core market capitalization, introducing structural advantages that directly benefit everyday retail investors:
· The Split Ratio: 10:1 (Ten equity shares will be issued for every one existing share held).
· Face Value Reduction: The face value per equity share will be adjusted from ₹10 to ₹1.
· Greater Affordability: By proportionally scaling down the absolute market price per share, the split lowers the financial barrier to entry, allowing smaller retail buyers to purchase whole shares.
· Enhanced Market Liquidity: An increased volume of outstanding shares moving through the capital market paves the way for higher trading volumes, tighter bid-ask spreads, and the ability to exit or enter positions with minimal price slippage.
· Entitlement Eligibility: Shareholders whose names appear in the company’s records or depositories as beneficial owners by the close of business hours on the revised date of Wednesday, July 8, 2026, will be entitled to receive the sub-divided shares.
Blockbuster Financial Highlights (As of March 2026)
This structural share split is heavily backed by robust, underlying fundamentals. According to the company's recently disclosed financial results for the fiscal period ended March 2026, Gujarat Inject (Kerala) Limited has delivered stellar year-on-year (YoY) numbers:
|
Financial Metric |
Quarter Ended March 2026 |
YoY Change (vs. March 2025 Quarter) |
Full Year Ended March 2026 |
YoY Change (vs. Full Year 2025) |
|
Net Sales / Revenue |
₹30.70 Crore |
⬆ 624.06% (from ₹4.24 Cr) |
₹36.32 Crore |
⬆ 90.66% (from ₹19.05 Cr) |
|
Net Profit (PAT) |
₹1.64 Crore |
⬆ 2,242.86% (from ₹0.07 Cr) |
₹1.81 Crore |
⬆ 77.45% (from ₹1.02 Cr) |
The company also continues to show expanding profit margins, improved return on equity (ROE), zero debt liabilities, and completely unpledged promoter holdings.
Transforming the Pipeline: Recent Major Solar Order Wins Further fuelling investor value, the company has secured a chain of multi-million rupee commercial contracts, establishing its place within India's solar infrastructure supply chain.
This comes during a proposed strategic corporate rebranding to Regenova Renewtech Limited to fully align its identity with clean energy solutions.
Recent operational wins include:
● · Deon Energy Limited Contract: A massive purchase order valued at ₹14.49 Crore (exclusive of GST) to supply and deliver 16,129 units of high-capacity (620 Wp) Solar Photovoltaic (PV) modules.
● · Ottire Lifestyle Private Limited Contract: An additional supply contract valued at ₹1.07 Crore for 1,334 units of specialized 600 Wp solar PV modules. ● · Pipeline Scalability: A separate solar module order finalized in early June valued at ₹6.07 Crore, bringing recent order wins to over ₹21.6 Crore—a significant commercial portfolio relative to the company’s previous fiscal size.
Management Commentary:
“The upcoming 10:1 sub-division of our equity shares reflects our ongoing effort to enhance market inclusivity,” said a GIKL Spokesperson. “Backed by an extraordinary 2,242% increase in our March quarterly net profit and over ₹21 Crore in recent solar order wins, we are executing a highly successful pivot into renewable energy. By establishing the revised Record Date as Wednesday, July 8, 2026, we look forward to welcoming a much broader public shareholder base into the Gujarat Inject family as we scale new heights.”